Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective.

van den Broek LJ, Limandjaja GC, Niessen FB, Gibbs S.

Exp Dermatol. 2014 Jun;23(6):382-6. doi: 10.1111/exd.12419. Review.

2.

Where we stand with human hypertrophic and keloid scar models.

Williams FN, Herndon DN, Branski LK.

Exp Dermatol. 2014 Nov;23(11):811-2. doi: 10.1111/exd.12506.

PMID:
25039250
3.

Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.

Verhaegen PD, van Zuijlen PP, Pennings NM, van Marle J, Niessen FB, van der Horst CM, Middelkoop E.

Wound Repair Regen. 2009 Sep-Oct;17(5):649-56. doi: 10.1111/j.1524-475X.2009.00533.x.

PMID:
19769718
4.

[Hyperplastic scars and keloids. Part I: basics and prevention].

Baisch A, Riedel F.

HNO. 2006 Nov;54(11):893-904; quiz 905. German.

PMID:
17041777
5.
6.

The molecular basis of keloid and hypertrophic scar formation.

Tuan TL, Nichter LS.

Mol Med Today. 1998 Jan;4(1):19-24. Review.

PMID:
9494966
7.

Keloids and hypertrophic scars: are they two different sides of the same coin?

Köse O, Waseem A.

Dermatol Surg. 2008 Mar;34(3):336-46. doi: 10.1111/j.1524-4725.2007.34067.x. Epub 2007 Dec 19. Review.

PMID:
18177398
8.

Management of scar contractures, hypertrophic scars, and keloids.

Sherris DA, Larrabee WF Jr, Murakami CS.

Otolaryngol Clin North Am. 1995 Oct;28(5):1057-68. Review.

PMID:
8559572
9.

Modeling aberrant wound healing using tissue-engineered skin constructs and multiphoton microscopy.

Torkian BA, Yeh AT, Engel R, Sun CH, Tromberg BJ, Wong BJ.

Arch Facial Plast Surg. 2004 May-Jun;6(3):180-7.

PMID:
15148128
10.

Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures.

Tziotzios C, Profyris C, Sterling J.

J Am Acad Dermatol. 2012 Jan;66(1):13-24; quiz 25-6. doi: 10.1016/j.jaad.2011.08.035. Review.

PMID:
22177632
11.

Scars and keloids.

Murray JC.

Dermatol Clin. 1993 Oct;11(4):697-708. Review.

PMID:
8222353
12.

Scar management: prevention and treatment strategies.

Chen MA, Davidson TM.

Curr Opin Otolaryngol Head Neck Surg. 2005 Aug;13(4):242-7. Review.

PMID:
16012249
13.

Regenerative healing, scar-free healing and scar formation across the species: current concepts and future perspectives.

Ud-Din S, Volk SW, Bayat A.

Exp Dermatol. 2014 Sep;23(9):615-9. doi: 10.1111/exd.12457. Epub 2014 Jul 21. Review.

PMID:
24863070
14.

Experimental keloid scar models: a review of methodological issues.

Hillmer MP, MacLeod SM.

J Cutan Med Surg. 2002 Jul-Aug;6(4):354-9. Epub 2002 Jul 16. Review.

PMID:
12118348
15.

The effect of the anti-allergic agent avil on abnormal scar fibroblasts.

Venugopal J, Ramakrishnan M, Habibullah CM, Babu M.

Burns. 1999 May;25(3):223-8.

PMID:
10323606
16.

Response to tissue injury.

Peled ZM, Chin GS, Liu W, Galliano R, Longaker MT.

Clin Plast Surg. 2000 Oct;27(4):489-500. Review.

PMID:
11039884
17.

Prevention and treatment of excessive dermal scarring.

Roseborough IE, Grevious MA, Lee RC.

J Natl Med Assoc. 2004 Jan;96(1):108-16. Review.

18.

Cutaneous scars: Part I.

Sahl WJ Jr, Clever H.

Int J Dermatol. 1994 Oct;33(10):681-91. Review. No abstract available.

PMID:
8002135
19.

Cutaneous tissue angiotensin-converting enzyme may participate in pathologic scar formation in human skin.

Morihara K, Takai S, Takenaka H, Sakaguchi M, Okamoto Y, Morihara T, Miyazaki M, Kishimoto S.

J Am Acad Dermatol. 2006 Feb;54(2):251-7.

PMID:
16443055
20.

Hypertrophic response and keloid diathesis: two very different forms of scar.

Burd A, Huang L.

Plast Reconstr Surg. 2005 Dec;116(7):150e-157e.

PMID:
16327593
Items per page

Supplemental Content

Write to the Help Desk